• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Sepsis Diagnostics Products and Market Trends

$3,000.00 – $6,000.00

Clear
SKU: 20-046 Category: Diagnostics Market Research Tags: biomarkers, COVID-19, mass spectrometry, sepsis, Sepsis Detection Pages: 58
  • Description
  • Table of Contents
  • Latest reports

Description

The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently.  In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths.  Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals.

  This report provides comprehensive information on products in the sepsis market, as well as:
  • Sepsis Detection Practice Trends
  • Sepsis Related Biomarkers: Advantages and Disadvantages
  • Markets for Sepsis-Related Testing
  • Mass Spectrometry and Sepsis
  • COVID-19 and Sepsis
  • Sepsis Testing Products on the Market  (Grouped by Technology, POC, AST, Culture/ID, NGS, Host Response, amp-free isothermal or alt, Approval Status)
The diagnosis of sepsis is not straightforward.  Blood culture analysis has remained a gold standard, despite the fact that it is typically slow and labor-intensive.  The complexity of sepsis and the overlap with infectious diseases causes this field to comprise a very large range of products and technologies.   This report takes into consideration the status of sepsis as a disease present within many other diseases.  A special section on COVID-19 is included.

This report does cover many of the systems and products that diagnose infectious diseases, with an emphasis on rapid or multiplexed tests; but it does not provide a comprehensive breakdown of products for infectious disease detection.  There is also a variety of other tests that are only touched upon, which also may be run depending on the appropriate action—blood gases, bilirubin, creatinine, platelets, etc.

Products from the following companies are considered in this report:

  • Abacus Diagnostica
  • Abaxis
  • Abbott
  • Abbott
  • Abcam
  • Abionic
  • Accelerate Diagnostics
  • Accellix
  • Acumen Research Laboratories
  • Affinity Biosensors
  • Alifax
  • Aperiomics
  • Assure Tech
  • Astrego Diagnostics
  • BacterioScan
  • Bacteromic (Scope Fluidics)
  • BD
  • Beckman Coulter
  • Biocartis
  • BioDirection
  • BioFire
  • BioInnovation Solutions
  • Biolog
  • bioMerieux
  • BioSense Solutions
  • Boditech Med
  • Bruker
  • Cepheid (Danaher)
  • Creative Diagnostics
  • Curetis
  • Curiosity Diagnostics (Scope Fluidics)
  • Cytobuoy
  • Cytovale
  • Day Zero Diagnostics
  • DiaSorin
  • Diazyme
  • DNA Electronics
  • EKF Diagnostics
  • ELITechGroup Solutions
  • Fujirebio
  • Fusion Genomics
  • GenePOC
  • Genmark Dx
  • Genomica SAU
  • GenSpeed Biotech
  • Gentian Diagnostics
  • GNA Biosolutions
  • GoDx
  • Gradientech
  • Great Basin Scientific
  • Hain Lifescience
  • Hardy Diagnostics
  • HelixBlind
  • Hologic
  • Horiba
  • iCubate
  • Immunexpress
  • ImpeDx
  • Inflammatix
  • Instrumentation Laboratory
  • Karius
  • LeucoDx
  • Liofilchem
  • Loop Diagnostics
  • Luminex
  • Lumos Diagnostics
  • MBio Diagnostics
  • Master Diagnostica
  • Medix Biochemica
  • Mednition
  • MeMed
  • Menarini Biosystems
  • Meridian Bioscience
  • Merlin Diagnostika
  • mFluiDx
  • MIDI, Inc.
  • Mitsubishi Chemical
  • Mobidiag
  • Mologic
  • Molzym
  • Momentum Bioscience
  • NanoCellect Biomedical
  • Nanomix
  • Molecular Biology Systems
  • Noscendo
  • Nova Biomedical
  • OnSiteGene
  • Ontera
  • OpGen
  • Orflo
  • Orion Diagnostica
  • Ortho Clinical Diagnostics
  • Oxford Nanopore
  • PathoQuest
  • PixCell Medical
  • PlexBio
  • Predigen Diagnostics
  • Q-linea AB
  • Qiagen
  • QuantaMatrix
  • Quidel
  • QuantuMDx
  • Qvella
  • Radiometer
  • RAMP Biomedical
  • Randox Laboratories/ Bosch Healthcare Solutions
  • ReanalytixAI
  • Roche
  • Rosco Diagnostica
  • Samsung
  • Scanogen
  • Seegene
  • SeLux Diagnostics
  • Sepset Biosciences
  • Siemens Healthineers
  • Specific Diagnostics
  • Spectrum Diagnostics
  • Sphingotec
  • SpinDiag
  • Stat-Diagnostica
  • Sysmex
  • T2 Biosystems
  • Talis Biomedical
  • Tangen Biosciences
  • TCS Biosciences
  • Thermal Gradient
  • Thermo
  • Torus Biosystems
  • Vela Diagnostics
  • Velox Biosystems

Table of Contents

CHAPTER 1: EXECUTIVE SUMMARY
OVERVIEW
PROFESSIONAL GUIDELINES AND DEFINITIONS

  • SIRS Criteria and Sepsis-1
  • Sepsis-2
  • Sepsis-3
  • Sequential (Sepsis-related) Organ Failure (SOFA), qSOFA

MARKET CONSIDERATIONS

    • Figure 1-1: Approximate Sepsis-Related Test Markets (CRP Market for All Applications, PCT Test Market for All Applications, Sepis-Purposed HAIs)

CHAPTER 2: TESTING OF HOST RESPONSE

    • Table 2-1: Top Biomarkers Used in Sepsis

PROCALCITONIN (PCT)

  • Advantages
  • Disadvantages

CRP

  • Advantages
  • Disadvantages

LACTATE
CYTOKINES
RNA, MRNA, MICRORNA (MIRNA)
PROADRENOMEDULLIN (PROADM)
D-DIMER
MULTI-MARKER APPROACHES

CHAPTER 3: PATHOGEN DETECTION/ IDENTIFICATION AND ANTIMICROBIAL SUSCEPTIBILITY TESTING
MULTIPLEX MOLECULAR ASSAYS
Multiplex Molecular Assays Used for Sepsis

    • Table 3-1: Multiplex Molecular Assays Used for Sepsis

MASS SPECTROMETRY ACHIEVING POPULARITY

  • Wide Selection of Products for Microbe ID, AST
    • Table 3-2: Selected Mass Spectrometry Products Used for Microbial ID and AST
    • Table 3-3: Systems and Products for Bacterial Culture, Staining, Incubation

CHAPTER 4: COVID-19 AND SEPSIS
COVID-19 AND OVERLAP WITH SEPSIS

CHAPTER 5: MAJOR SEPSIS-RELATED PRODUCTS ON THE MARKET

    • Table 5-1: Sepsis Products on the Market
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Clinical Diagnostics in China – Market Sector Analyses and Participant Directory

    $4,995.00 – $9,990.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease

    $1,995.00 – $3,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Worldwide Market for Laboratory-Developed Tests (LDTs)COVID-19 Update, Clinical Testing, Telehealth, Vaccines and Other Markets
Scroll to top